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Effectiveness of 10% povidone-iodine drying time before 
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Aim: to investigate the effectiveness of 10% povidone-iodine after a 30-second or 2-minute 
drying time on microbial count reduction at the point of a Peripheral Intravascular Catheter (PIC) 
insertion. A quasi-experimental design was adopted. In total, 53 patients were enrolled, 25 
were exposed to a 2-m drying time and 28 to a 30-s drying time. From the preliminary results 
of this study, no differences in the occurrence of contamination have emerged between patients 
receiving 30-s and 2-m drying time for 10% povidone-iodine solutions.
Descriptors: Povidone Iodine/Therapeutic Use; Air Dry; Disinfection; Catheterization Peripheral; 
Microbial Count.
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Eficácia de iodopovidona a 10% de acordo com tempo de secagem antes da 
inserção do cateter intravenoso periférico: resultados preliminares de um 
estudo exploratório quasi-experimental
Objetivo: investigar a eficácia da solução iodopovidona a 10% sobre a redução da contagem 
microbiana no ponto de inserção do Cateter Venoso Periférico após tempo de secagem de 30s 
ou 2 min. Método: desenho quase-experimental. Foram incluídos 53 pacientes no estudo: 25 
foram expostos a 2min de secagem e 28 foram expostos a 30s de secagem. Resultados: Os 
resultados preliminares não apresentaram diferenças na ocorrência de contaminação entre os 
pacientes que foram submetidos a 30s ou 2min de secagem após desinfecção com solução de 
iodopovidona a 10%.
Descritores: Iodopovidona/Uso Terapêutico; Desinfecção; Cateterismo Periférico; Contagem 
Microbiana.
Background
cell wall of the microorganism and to replace the content 
with iodine(7).The previous guidelines on intravascular 
catheters(5-6) recommend allowing for a drying time of 2 
minutes, but no experimental data support this advice. 
Previously, commentary that likewise lacks support from 
experimental data reported that a 10% povidone-iodine 
solution would be effective after drying for 90 seconds(8).
In daily practice, nurses have many doubts about 
the time required and different strategies to facilitate 
drying are adopted: fanning, using gauze to dry, and 
blowing, which seems to be inappropriate as it increases 
the risk of infection(7). These strategies are often adopted 
in the use of 10% povidone-iodine because its drying 
time appears to be longer than for other solutions. 
Contributing to knowledge regarding how long the 10% 
povidone-iodine should be left in place before applying 
the PIC is the main goal of this paper.
The Peripheral Intravascular Catheter (PIC) is 
widely used in nursing clinical practice. PICs can cause 
both local and systemic complications, the most common 
being phlebitis, varying from 1–70% in different 
observational studies(1-3), and originate most often from 
skin commensal flora. Recommended strategies to 
prevent PIC-related infections are hand hygiene, the use 
antiseptic techniques and adequate skin preparation(4-6). 
Before the placement of a PIC, an effective reduction 
of the microbial count is recommended. While different 
antiseptic solutions should be used (e.g., >0.5% 
chlorhexidine, iodophor), there is a general lack of 
recommendations regarding the disinfection drying time, 
even in the most recent guidelines(4). In the event of 
contraindication of the use of chlorhexidine(4), a solution 
with 10% povidone-iodine is recommended and drying 
time is necessary for it to release free iodine against the 
Eficacia del tiempo de secado de la yodopovidona al 10% antes de la 
inserción de catéter venoso periférico: resultados preliminares de un 
estudio exploratorio casi-experimental
Objetivo: para investigar la eficacia de una solución yodopovidona al 10% tras tiempo de 
secado de 30 segundos o 2 minutos en la reducción del contaje microbiano en el local de 
inserción del Catéter Venoso Periférico, fue adoptado un diseño casi-experimental. Al total, 
fueron incluidos 53 pacientes, 25 expuestos a 2 min. de secado y 28 a 30 segundos. Con base en 
los resultados preliminares, no se encontraron diferencias en la ocurrencia de contaminaciones 
entre pacientes sometidos a un tiempo de secado de 30 s. o de 2 min tras desinfección con 
solución de yodopovidona al 10%.
Descriptores: Povidona Yodada/Uso Terapéutico; Desinfección; Cateterización Periférica; 
Recuento Microbiano.
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Objectives and study design
Aiming to investigate the effectiveness of 10% 
povidone-iodine after a 30-second or 2-minute drying 
time on microbial count reduction at the point of PIC 
insertion, a quasi-experimental design was adopted.
Materials and methods
In February 2012, an approachable Emergency 
Department (ED) located in northern Italy was involved 
after having obtained appropriate authorization from the 
Internal Review Board of the Hospital/University.
All adults (≥18 years) admitted subsequently to the 
ED and who were candidates for PIC were eligible. Those 
affected by condition(s) contraindicating the adoption 
of 10% povidone-iodine (e.g., allergy, pregnancy) or 
affected by cardiac arrest or unconsciousness were 
excluded. After having obtained written informed 
consent from the patients included in the study, they 
were divided into two groups according to the priority 
given at triage: a) those receiving an ED white code 
(=not urgent condition) were exposed to a 2 minute 
(2-m) 10% povidone-iodine drying time, while b) those 
receiving green or yellow triage codes (=patients in sub-
urgent conditions) were exposed to a 30 second (30-
s) drying time. Clinical nurses disinfected the site with 
10% povidone-iodine using sterile gauze, in accordance 
with the procedure adopted in the ward.
The microbial count was the primary end-point 
of the study, examined at two different points in time: 
the first, before skin disinfection, seeking to determine 
baseline skin contamination (T0), the second after the 
drying time (30-s vs. 2-m), in order to measure the 
effectiveness of 10% povidone-iodine on the microbial 
count at a different drying time (T1). The swabs were 
immediately seeded on chocolate agar and conserved 
in a thermostat-governed environment at 37° Degree 
Celsius (C) for 24 hours and then evaluated by two 
researchers in a blind fashion to count the colony-
forming units (CFUs). The definition adopted for skin 
contamination was the presence of CFUs≥15(9).
A questionnaire investigating patient demographic 
characteristics such as age and gender, recent 
surgery (yes/no), health problems (cancer, diabetes, 
coagulopathies, fever -yes/no-), and antibiotic therapy 
(yes/no) according to their influence in the occurrence of 
PIC-related infection(10-14) was administered by interview.
Patient collaboration (or not) during the procedure, 
where the PIC was inserted (e.g., right or left upper 
limb, and vein approached), and its size, as well as 
factors increasing the risk of contamination(3,10-14), were 
also observed and documented by the researcher. 
Ultimately, skin preparation procedures adopted by the 
clinical nurse performing the PIC insertion (preliminary 
hand hygiene, the use of gloves, and the adoption of 
aseptic techniques during the procedure, in accordance 
with the available guidelines(4)) was then observed, with 
a grid filled in by the researcher.
Data was processed using the SPSS Statistical 
Package (Version 18). Indices of central position (mean, 
standard deviation), percentages and frequencies have 
been evaluated. Comparison between the two groups 
was performed adopting the T-test or non-parametric 
tests (according to the normal distribution [or not] of 
the variables), and the χ2 test (or Fisher’s Test, when 
appropriate). Relative Risk (Confidence Interval 95% 
[95% CI]) was also evaluated. The statistical significance 
level was set at p=0.05.
Results
In total, some 53 patients were enrolled, 25 were 
exposed to a 2-m drying time and 28 to a 30-s drying 
time. Thirty–one patients were male, and the majority 
(50/53, 94.3%) collaborated with clinical nurses 
during the PIC insertion. The exposed and control 
groups were homogeneous in their principal participant 
characteristics, as reported in Table 1. The procedure for 
PIC insertion and the characteristics of the PIC gauge 
and of the site chosen by the clinical nurse were also 
homogeneous between the exposed and control groups, 
as indicated in Table 1.
Exposed Group 
30-s=28 (%)
Control Group 
2-m =25 (%)
P 
value*
Patient characteristics
Age 68.2 (SD 19.7) 63.2 (SD 18.8) 0.35
Male 17 (60.7) 14 (56.0) 0.47
Recent surgery (yes) 2 (7.1) 0 (-) 0.27
Cancer (yes) 2 (7.1) 1 (4.0) 0.54
Diabetes (yes) 3 (10.7) 3 (12.0) 0.60
Coagulopathies (yes) 14 (50.0) 10 (40.0) 0.32
Fever at the time of 
ED admission (yes) 3 (10.7) 2 (8.0) 0.55
Antibiotics at the time 
of ED admission (yes) 2 (7.1) 5 (20.0) 0.16
Patient collaboration 
(yes) 27 (96.4) 23 (92.0) 0.45
PIC insertion
Site: Right upper limb 16 (57.1) 16 (64.0) 0.61
Antecubital fossa 14 (50.0) 17 (68.0)
0.16Forearm 11 (39.3) 8 (32.0)
Hand 3 (10.7) 0 (-)
Table 1 - Patient demographics and PIC insertion data
(continue...)
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At an overall level, 27 out of 53 (50.9%) sites 
selected for PIC placements were contaminated at 
the baseline (T0; 17 among the exposed group and 
10 among the control group); after disinfection (T1), 
20 sites (37.7%) were contaminated (13 among 
the exposed group and 7 among control groups). A 
total of 7 contaminated sites (13.2%) at T0 were not 
contaminated at T1 (4 among the exposed group and 3 
among the control group). The differences that emerged 
were not statistically significant (Table 2).
Discussion
According to its exploratory nature, this manuscript 
has several limitations: a monocentric center was involved 
and a limited number of participants were enrolled. 
Adopting the perspective of pragmatic trials(15), the 
researchers did not standardize the disinfection technique, 
given that the quantity of antiseptic solution used in daily 
practice for this procedure is adopted heterogeneously 
among clinical nurses. Further studies should address 
these limits, extending the study design also to those 
antiseptic solutions recommended by the up-to-date 
guidelines (e.g., >0.5% chlorhexidine, iodophor) and also 
at different sites, such as for surgical wound disinfection.
The study involved a homogeneous group of patients 
admitted into the ED under different urgency codes where 
the insertion of a PIC is considered a routine procedure. 
According to the need to have the PIC rapidly in place 
(in the case of urgent cases), a group was exposed to a 
30-s drying time, while patients admitted in non-urgent 
conditions received a 2-m drying time. Considering the 
lack of evidence available in the field, the drying time was 
selected on the basis of the existing literature(7), which 
recommended 2 minutes, and on the basis of in vitro 
studies(16-17), which applied a 30-s drying time.
The analysis showed that drying time (30-s vs. 
2-m) was not significantly associated with contamination 
(CFUs≥15) at T1: in its preliminary phase and among 
its several limitations, this exploratory study shows that 
the drying time should be less than 2 minutes and these 
results might help nurses in their practice. For them, 
waiting for the drying time is particularly difficult in the 
case of confused, unstable and at risk patients and/or in 
turbulent environments such as EDs(18), where multiple 
interruptions might threaten the safety of the procedure. 
In order to reduce this time, different strategies are 
adopted by clinical nurses, such as fanning, using gauze 
to dry, or blowing, which seems to be inappropriate as it 
increases the risk of infection(7).
Conclusions
Intravenous therapy is largely used for ED patients 
via PICs inserted by nurses. PICs can cause both local and 
systemic complications, the most common being phlebitis: 
aseptic techniques and adequate skin preparation are the 
main strategies to reduce contamination at the time of 
insertion. To our knowledge, no previous studies developed 
evidence regarding the drying time utilized after skin 
disinfection or its effectiveness in reducing contamination. 
From the preliminary results of this study, no differences 
Veins approached
Cephalic vein 16 (57.1) 14 (56.0)
0.19
Basilic vein 8 (28.6) 7 (28.0)
Perforating vein 1 (3.6) 1 (4.0)
Dorsal vein 3 (10.7) 0 (-)
Median antebrachial 
vein 0 (-) 3 (12.0)
PIC size
18 gauge 20 (71.4) 13 (52.0)
0.2420 gauge 8 (28.6) 11 (44.0)
22 gauge 0 (-) 1 (4.0)
Skin preparation procedure adopted by the nurse inserting 
the PIC
Hand hygiene (yes) 2 (7.1) 4 (16.0) 0.31
Gloves (yes) 10 (35.7) 13 (52.0) 0.23
Aseptic technique 
respected (yes) 1 (3.6) 5 (20.0) 0.06
Table 1 - (continuation)
*χ2 for categorical variables and U-Mann Whitney for continuous variables
Characteristics Exposed Group 30-s=28 (%)
Control 
Group 
2-m=25 (%)
P value
Number of 
PIC sites 
contaminated 
(CFUs≥ 15) 
at T0
17 (60.7) 10 (40.0)
RR 1.49
(CI95% 0.87 to 
2.54)
p = 0.13
Number of 
PIC sites 
contaminated 
(CFUs≥15) at T1
13 (47.4) 7 (28.0) RR 1.43
(CI95% 0.87 to 
2.34)
p = 0.16
Differences 
of PIC sites 
contaminated 
(CFUs≥ 15) 
(T1-T0)
4 (14.3) 3 (12.4)
RR 1.10
(CI95% 0.54 to 
2.20)
p = 0.80
Table 2 - Disinfection with 10% povidone-iodine: 
comparison between exposed group and controlled group
Moreover, among the group with a 30-s drying 
time, the average of CFUs at T0 were 209 and 80 at 
T1 (-24.6%); among the control group (2-m drying 
time), the average CFUs at T0 were 4,527 and 502 
at T1 (-35.3%). These differences are not statistically 
significant (p=0.268).
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in the occurrence of contamination have emerged 
between patients receiving 30-s and 2-m drying time of 
10% povidone-iodine solutions. These preliminary results 
should be confirmed with further large and multicenter 
studies addressing the lack of evidence in the field and 
the consequent uncertainly of clinical nurses: drying 
time increases the length of the procedure and the risk 
of accidental contamination of the site. Waiting for a site 
to dry for a longer time with some patients (e.g. critical, 
agitated patients), and in some turbulent environments 
(e.g. emergency departments) is not always advisable.
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